KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elanco Animal Health (ELAN) Cash from Financing Activities (2017 - 2025)

Elanco Animal Health's Cash from Financing Activities history spans 9 years, with the latest figure at -$18.0 million for Q4 2025.

  • For Q4 2025, Cash from Financing Activities rose 43.75% year-over-year to -$18.0 million; the TTM value through Dec 2025 reached -$275.0 million, up 81.57%, while the annual FY2025 figure was -$275.0 million, 81.57% up from the prior year.
  • Cash from Financing Activities for Q4 2025 was -$18.0 million at Elanco Animal Health, up from -$153.0 million in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $231.0 million in Q3 2021 and bottomed at -$1.3 billion in Q3 2024.
  • The 5-year median for Cash from Financing Activities is -$75.5 million (2021), against an average of -$109.4 million.
  • The largest annual shift saw Cash from Financing Activities soared 344.44% in 2021 before it plummeted 10100.0% in 2022.
  • A 5-year view of Cash from Financing Activities shows it stood at $44.0 million in 2021, then crashed by 290.91% to -$84.0 million in 2022, then tumbled by 65.48% to -$139.0 million in 2023, then soared by 76.98% to -$32.0 million in 2024, then soared by 43.75% to -$18.0 million in 2025.
  • Per Business Quant, the three most recent readings for ELAN's Cash from Financing Activities are -$18.0 million (Q4 2025), -$153.0 million (Q3 2025), and -$156.0 million (Q2 2025).